CRISPR Therapeutics AG (CRSP)
Retained Earning Schedule
|Retained Earnings (Previous Year)||-574||-225||-292||-125||-|
Intangible and Goodwill Schedule
|Intangible and Goodwill (Previous Year)||-||-||-||-||-|
|Intangible and Goodwill||-||-||-||-||-|
CRISPR Therapeutics AG income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes CRISPR Therapeutics AG FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.